Biography
Dr Sophie Morse is an Emerging Leader at the UK DRI at Imperial, sponsored by Group Leader Prof Paul Matthews, and an Imperial College Research Fellow.
With a background in Biomedical Engineering, Dr Sophie Morse completed her PhD between King’s College and Imperial College, where she developed a novel non-invasive method to improve the delivery of drugs to the brain using focused ultrasound and microbubbles.
In 2020, she received an EPSRC Doctoral Prize Fellowship to deliver a novel drug against Alzheimer’s disease with this ultrasound technology. Dr Morse has won over 20 awards for her work, including the Top 50 Women in Engineering Award, the William James Award from the Institute of Engineering and Technology, as well as the Gold Medal in Engineering and the Westminster Medal at STEM for Britain.
Her current research is focused on developing ultrasound technology to non-invasively modulate the activity of glial cells to delay the onset of neurodegenerative diseases and promote healthy brain ageing.
Morse Lab
Explore the work of the Morse Lab deploying focused ultrasound technologies to stimulate glia to treat dementia
